Chlorhexidine + Ketoconazole + Phytosphingosine

30 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

330.0%

Death Rate

Active Ingredients

ChlorhexidineChlorhexidine + Ketoconazole + PhytosphingosineKetoconazolePhytosphingosine

Administration Routes

TopicalAuricular (Otic)UnknownCutaneous

Species Affected

Dog 28

Human 1

Cat 1

Most Affected Breeds

Crossbred Canine/dog 3

Havanese 2

Terrier - Jack Russell 2

Pug 2

Spaniel - Cocker American 2

Retriever - Labrador 2

Chihuahua 1

Dachshund - Miniature 1

Shih Tzu 1

Schnauzer - Miniature 1

Most Reported Reactions

Vomiting 4

Pruritus 4

Lack of efficacy - NOS 4

Emesis 3

Pustules 3

Application site erythema 3

Skin irritation 3

Ear discharge 3

Lethargy (see also Central nervous system depression in 'Neurological') 2

Not eating 2

Localised pain NOS (see other 'SOCs' for specific pain) 2

Behavioural disorder NOS 2

Outcome Breakdown

Outcome Unknown

11 (36.7%)

Recovered/Normal

11 (36.7%)

Ongoing

6 (20.0%)

Died

1 (3.3%)

Recovered with Sequela

1 (3.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.